Translational research comes of age
- 1 September 1996
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 2 (9) , 974-975
- https://doi.org/10.1038/nm0996-974
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.Nature Medicine, 1996
- COMMENTARY: p53 Tumor suppressor gene: from the basic research laboratory to the clinic—an abridged historical perspectiveCarcinogenesis: Integrative Cancer Research, 1996
- Cell-cycle control and its watchmanNature, 1996
- Therapeutic Effect of a Retroviral Wild-Type p53 Expression Vector in an Orthotopic Lung Cancer ModelJNCI Journal of the National Cancer Institute, 1994
- Somatic Mutations of the MTS (Multiple Tumor Suppressor) 1/CDK41 (Cyclin-Dependent Kinase-4 Inhibitor) Gene in Human Primary Non-small Cell Lung CarcinomasBiochemical and Biophysical Research Communications, 1994
- p53 mutations in lung cancers from non-smoking atomic-bomb survivorsThe Lancet, 1993
- Stable Expression of the Wild-Typep53Gene in Human Lung Cancer Cells after Retrovirus-Mediated Gene TransferHuman Gene Therapy, 1993
- Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1.Proceedings of the National Academy of Sciences, 1992
- p53: A Frequent Target for Genetic Abnormalities in Lung CancerScience, 1989